Konkuk University Medical Center
Seoul, 143-729, South Korea
NCT Number: NCT03366753
Acute normovolemic hemodilution (ANH) has long been employed for reducing allogenic blood transfusion for cardiac surgery, and hydroxyethyl starch has been used as an intravenous replacement fluid during ANH procedure. However, possible impact of ANH employing HES on blood viscosity and oxygen delivery have not been well investigated in patients undergoing off-pump coronary artery bypass (OPCAB) surgery .
Anesthesia is induced and maintained by using propofol-remifentanil-rocuronium in OPCAB surgery (n=21). ANH is performed by using 5 ml/kg of blood salvage and administering 5 ml/kg of balanced HES 130/0.42 (Tetraspan™) for 15 min during vascular graft harvesting. For the present study, three arterial blood samples (3 ml each) are taken before (Sample 1) and after ANH (sample 2 and 3) and they are stored in 3 tubes. Sample 3 (in tube) undergoes further 30% in-vitro dilution by adding 1-1.5 ml HES. By using a scanning capillary tube viscometer (Hemovister™), Blood viscosity at low shear rate (5/sec) of the three samples are determined. By using a formula with blood viscosity and hematocrit, tissue O2 delivery index (TODI, = hematocrit/viscosity at 5/sec) is calculated.
Looking for future studies?
Notify MeAll sexes
Interventional
Not applicable
Seoul, 143-729, South Korea
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
acute normovolemic hemodilution (ANH) is performed by using 5 ml/kg of blood salvage and intravenously administering 5 ml/kg of balanced hydroxyethystarch 130/0.42 (Tetraspan™) for 15 min
Blood sample after ANH 5 ml/kg undergoes further 30% in-vitro dilution by adding 1-1.5 ml hydroxyethystarch 130/0.42
Time frame: 5 min after acute normovoelmic hemodilution, 5 min after in-vitro dilution
By using a scanning capillary tube viscometer (Hemovister™), Blood viscosity at shear rate 5/sec of the three samples are determined
Time frame: 5 min after acute normovoelmic hemodilution, 5 min after in-vitro dilution
oxygen delivery index calculated with a formula (= hematocrit/blood viscosity)
Time frame: 5 min after acute normovoelmic hemodilution, 5 min after in-vitro dilution
By using a scanning capillary tube viscometer (Hemovister™), Blood viscosity at shear rate 300/sec of the three samples are determined
Time frame: 5 min after acute normovoelmic hemodilution, 5 min after in-vitro dilution
oxygen delivery index calculated with a formula (= hematocrit/blood viscosity)
Time frame: 5 min after acute normovoelmic hemodilution, 5 min after in-vitro dilution
clot formation time in extem, MCF in extemA5 in fibtem,
Konkuk University Medical Center
Other
Impact of Intravascular Fluid Resuscitation for Acute Normovolemic Hemodilution on Blood Viscosity and Oxygen Delivery in Coronary Artery Bypass Graft Surgery
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04175626
Acute Coronary Syndrome, Angina Pectoris
Fairhope, Alabama, United States
View Trial DetailsNCT03567733
Arterial Occlusive Diseases, Arteriosclerosis
Almada, Portugal
View Trial DetailsNCT06181799
Angina Pectoris, Arterial Occlusive Diseases
Moscow, Russia
View Trial DetailsNCT04475536
Arterial Occlusive Diseases, Arteriosclerosis
Santiago de Compostela, LA Coruña, Spain
View Trial Details